Home > NewsRelease > ASTRO: The Lancet study further confirms radiation benefits
Text
ASTRO: The Lancet study further confirms radiation benefits
From:
American Society for Radiation Oncology American Society for Radiation Oncology
,
Tuesday, October 25, 2011

 
Press Release
Contact: Beth Bukata

703-839-7332

bethb@astro.org

Nicole Napoli

703-839-7336

nicolen@astro.org
ASTRO: The Lancet study further confirms radiation benefits

Fairfax, Va., October 25, 2011 - The American Society for Radiation Oncology (ASTRO) commends the recent paper published in The Lancet confirming that radiation therapy after surgery for early-stage breast cancer patients reduces the risk that the cancer will recur or spread 10 to 15 years following treatment.

Spreading the word that this life-saving treatment will help women keep their breasts and avoid a potentially disfiguring mastectomy while allowing them to live long, cancer-free lives is an important mission of ASTRO, and we applaud the recent manuscript in The Lancet for further bringing light to the issue. The article also featured a commentary by Thomas Buchholz, MD, a radiation oncologist at MD Anderson Cancer Center and a senior editor of ASTRO's clinical research journal, the International Journal of Radiation Oncology?Biology?Physics.

"The fact that radiation reduces the risk of recurrence in the breast has been demonstrated in multiple studies. This analysis confirms that radiation not only reduces the risk of local recurrence but improves overall cure rates and survival," Bruce Haffty, MD, FASTRO, chairman of radiation oncology at Robert Wood Johnson University Medical School in New Brunswick, N.J., and  a member of ASTRO's Breast Cancer Resource Panel, said. "However, many women still do not receive radiation to keep their cancer from returning. I hope this article gives breast cancer patients, their families and caregivers peace of mind when considering cancer treatments."

In the article, the group conducted an analysis of 17 breast cancer studies that included approximately 11,000 breast cancer patients. Results showed that radiation after surgery reduced the recurrence risk by half and the death rate by approximately one-sixth compared to women who had surgery alone.

Today, lumpectomy plus radiation is the standard treatment for early-stage breast cancer patients. And while the benefits of radiation therapy for these women has been repeatedly proven, many women still do not receive the necessary radiation they need to ensure their breast cancer stays in remission.

We encourage patients to speak with their doctors about every option for treating their breast cancer, including radiation therapy, and we encourage referring physicians to explain to eligible early-stage breast cancer patients that lumpectomy and radiation therapy can cure their cancer and eliminate the need for a mastectomy.

For more information on radiation therapy for breast cancer, visit www.rtanswers.org.

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information on radiation therapy, visit www.rtanswers.org. To learn more about ASTRO, visit www.astro.org.

###

8280 Willow Oaks Corporate Drive, Suite 500, Fairfax VA 22031

phone: 1-800-962-7876, phone: 703-502-1550, fax:703-502-7852, Web: www.astro.org
News Media Interview Contact
Title: Media Relations Manager
Group: American Society for Radiation Oncology
Dateline: Arlington, VA United States
Direct Phone: 703-286-1600
Main Phone: 703-502-1550
Jump To American Society for Radiation Oncology Jump To American Society for Radiation Oncology
Contact Click to Contact